FTXH
First Trust Nasdaq Pharmaceuticals ETFNASDAQ
Updated 1 day ago
Coverage limited
$40.43-1.99%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -0.7%
- 3 months
- +6.6%
- 1 year
- +39.8%
- 52-week range
- $28.93$42.76
- Dividend, last 12 mo
- $0.29 · 0.72% yield
- Last ex-date
- Sep 24, 2026 · $0.0113
- Dividend growth
- 2 years in a row
- Short interest
- 9.5K sharessettled Sep 30, 2026 · -50.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if FTXH is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
3 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
31 filers reported a long position in FTXH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| LPL Financial LLC | $5.8M | 151.5K | -14.7% |
| OPPENHEIMER & CO INC | $4.4M | 114.2K | +181.6% |
| RAYMOND JAMES FINANCIAL INC | $2.1M | 55K | +369.1% |
| TRUIST FINANCIAL CORP | $2M | 52.1K | -8.7% |
| MARSHALL INVESTMENT MANAGEMENT, LLC | $1.5M | 38.1K | -15.8% |
| Ameritas Investment Partners, Inc. | $1.3M | 34K | +13% |
| Cambridge Investment Research Advisors, Inc. | $1.2M | 30.5K | +56.2% |
| Nilsine Partners, LLC | $1.1M | 28.1K | +3.5% |
| ROYAL BANK OF CANADA | $547K | 14.3K | +28,544% |
| GOLDMAN SACHS GROUP INC | $524.3K | 13.7K | -29.1% |
Get the Full Analysis for FTXH
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.